Phibro Animal Health reported $78.42M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Align Technology ALGN:US USD 619.17M 68.39M
Ani Pharmaceuticals ANIP:US USD 50.93M 12.37M
Aurora Cannabis Inc ACB:CN CAD -22824000 580K
Bristol Myers Squibb BMY:US USD 8.86B 345M
Canopy Growth Corp WEED:CN CAD 3.82M 5.21M
Corcept Therapeutics CORT:US USD 100.39M 1.68M
Eli Lilly And LLY:US USD 5.36B 305M
Endo International Ordinary Shares ENDP:US USD 364.83M 28.49M
Henry Schein HSIC:US USD 914M 31M
Idexx Laboratories IDXX:US USD 506.63M 7.41M
Knight Therapeutics Inc GUD:CN CAD 30.4M 7.89M
Lannett LCI:US USD 12.6M 4.74M
Merk MRK:US USD 11.52B 1.08B
Nektar Therapeutics NKTR:US USD 18.65M 2.18M
Pacira Pharmaceuticals PCRX:US USD 116.79M 2M
Patterson Companies PDCO:US USD 312.13M 36.11M
Prestige Brands PBH:US USD 161.01M 890K
Teva Pharmaceutical Industries TEVA:US USD 1.71B 118M
Zoetis ZTS:US USD 1.4B 36M